Monarch Capital Management Inc Bristol Myers Squibb CO Transaction History

Monarch Capital Management Inc

$365 Million
Q3 2024

A detailed history of Monarch Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Monarch Capital Management Inc holds 24,458 shares of BMY stock, worth $1.38 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

24,458

Previous 24,228 0.95%

Holding current value

$1.38 Million

Previous $1.01 Million 25.75%

% of portfolio

0.35%

Previous 0.3%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$39.66 - $51.75 $9,121 - $11,902	230 Added 0.95%	24,458 $1.27 Million
Q2 2024 Jul 24, 2024	SELL	$40.25 - $52.99 $34,776 - $45,783	-864 Reduced 3.44%	24,228 $1.01 Million
Q1 2024 Apr 25, 2024	SELL	$47.98 - $54.4 $95 - $108	-2 Reduced 0.01%	25,092 $1.36 Million
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $10,908 - $13,016	-225 Reduced 0.89%	25,094 $1.29 Million
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $12 - $7,376	-96 Reduced 0.38%	25,319 $1.8 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $2,396 - $2,639	-33 Reduced 0.13%	25,415 $1.96 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $2,414 - $2,629	-39 Reduced 0.15%	25,448 $1.7 Million
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $6,409 - $7,262	-111 Reduced 0.43%	25,487 $1.58 Million
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.39%	25,598 $1.54 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $61,946 - $72,421	-1,130 Reduced 4.21%	25,698 $1.51 Million
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $41,713 - $60,619	-899 Reduced 3.24%	26,828 $1.5 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $92,268 - $120,356	1,875 Added 7.25%	27,727 $1.78 Million
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.39%	25,852 $1.23 Million
Q4 2018 Jan 23, 2019	SELL	$48.76 - $63.23 $14,628 - $18,969	-300 Reduced 1.14%	25,952 $1.35 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $13,797 - $15,562	-250 Reduced 0.94%	26,252 $1.63 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $30,823 - $38,417	-610 Reduced 2.25%	26,502 $1.47 Million
Q1 2018 Apr 18, 2018	SELL	$59.92 - $68.98 $7,490 - $8,622	-125 Reduced 0.46%	27,112 $1.72 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $59,940 - $65,349	-1,000 Reduced 3.54%	27,237 $1.67 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $1.56 Million - $1.8 Million	28,237	28,237 $1.8 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Bristol Myers Squibb CO Transaction History